SCHEMBL2884387

SCHEMBL2884387

Cc1cc(-n2ccc(C(F)(F)C(F)(F)F)n2)ccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.39
KDM4E B2RXH2 3/20 0.39
RAD52 P43351 2/20 0.39
NPC1 O15118 8/20 0.38
PRMT6 Q96LA8 1/20 0.38
RAB9A P51151 6/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
GAA P10253 3/20 0.35
THRB P10828 1/20 0.35
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34
MCL1 Q07820 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPK1 P28482 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2161196 0.88 PRMT6 (0.49) MAPTKDM4ERAD52NPC1PRMT6
SCHEMBL1837562 0.78 HPGD (0.45) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL16202042 0.75 MAPT (0.52) MAPTKDM4ENPC1PRMT6RAB9A
SCHEMBL2889812 0.75 KDM4E (0.42) MAPTKDM4ERAD52NPC1RAB9A
SCHEMBL2161783 0.74 ALDH1A1 (0.41) MAPTKDM4ERAD52NPC1RAB9A
SCHEMBL2161143 0.74 ALDH1A1 (0.31) ALDH1A1CYP3A4TSHRTDP1
SCHEMBL2889321 0.73 RAD52 (0.38) MAPTKDM4ERAD52NPC1RAB9A
SCHEMBL1833528 0.72 KDM4E (0.53) MAPTKDM4ERAD52NPC1RAB9A
SCHEMBL21315880 0.71 NPC1 (0.39) MAPTKDM4ENPC1PRMT6RAB9A
SCHEMBL16911724 0.71 NPC1 (0.51) MAPTKDM4ENPC1PRMT6RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674807-B2 Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides BAYER CROPSCIENCE AG (DE) 2010-03-09 US disclosed
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides BAYER CROPSCIENCE AG (DE) 2007-12-27 US disclosed
EP-1727804-A1 N1 - ((PYRAZOL-1-YMETHYL) -2-METHYLPHENYL)- PHATALAMIDE DERIVATIVES AND RELATED COMPOUNDS INSECTICIDES Bayer CropScience Aktiengesellschaft (DE) 2006-12-06 EP disclosed
WO-2005095351-A1 N1 - ((PYRAZOL-1-YMETHYL) -2-METHYLPHENYL)- PHATALAMIDE DERIVATIVES AND RELATED COMPOUNDS INSECTICIDES BAYER CROPSCIENCE AG (DE) 2005-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides CHRM1, KCNH1, DDT MAPT 3425/4885KDM4E 560/4885RAD52 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.